首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
考研
Obesity is an epidemic to some and an opportunity to others. More than two-thirds of Americans are overweight. Find a way to bat
Obesity is an epidemic to some and an opportunity to others. More than two-thirds of Americans are overweight. Find a way to bat
admin
2018-01-31
45
问题
Obesity is an epidemic to some and an opportunity to others. More than two-thirds of Americans are overweight. Find a way to battle obesity, 【C1】______a huge profit might be made. On February 22nd, 2013 one pharmaceutical firm, Vivus, took a small【C2】______towards this goal. A committee advising America’ s Food and Drug Administration(FDA)recommended Vivus’ s diet drug, Qnexa.【C3】______, the pill’ s long-awaited final approval may not come until April. The announcement mostly served as a reminder of a struggle which【C4】______fat into gold.
Medical-device and pharmaceutical companies are quite【C5】______treating the problems that come with obesity. However, they can’t help consumers【C6】______weight. Allergan, a device-maker, has tried to use its gastric bands to enter the obesity market. The band is fitted near the top of patients’ stomach, which helps them feel full【C7】______during the meal. Allergan has captured about 70% of the worldwide market for gastric bands, but sales are now【C8】______. The recession has sapped consumers’ desire for expensive surgery. Some patients have【C9】______bands removed because they slipped or proved【C10】______. In January David Pyott, Allergan’s chief executive, said he would cancel an effort to market the band for teenagers. He is now trying to convince insurers of the gastric band’ s【C11】______.
Drug companies have had even more【C12】______than device-makers. It has been 13 years since the FDA approved a【C13】______diet pill. That drug, Roche’s Xenical, has【C14】______side-effects. The FDA rejected Vivus’s Qnexa in 2010 over【C15】______for the safety of pregnant women and the quickening of patients’ heart rates.
However, Vivus’ s new data in 2013 apparently satisfied the FDA’ s advisory committee.
But the agency may yet【C16】______the drug.【C17】______Qnexa is approved, it is unclear that patients will buy it. Qnexa【C18】______two medicines that are already on the market. Both medicines are generic, which means that doctors may【C19】______the existing drugs rather than Qnexa’s more expensive version. For now, it is more【C20】______to treat fat patients than to try to make them slim.
【C4】
选项
A、turns
B、modifies
C、alters
D、converts
答案
A
解析
本题考查动词辨析及固定搭配。根据文章和选项,可知此处意为“公告主要是提醒人们,这是一场点‘肥’成金的斗争”,turn sb./sth.into sth.意为“使(从……)变成”,故A.turns指外形、颜色、气味、性质等方面的变化,为正确答案。modify强调起限定作用的变化或变更,常含“缓和、降调”的意味;alter常指轻微的改变,强调基本上保持原物、原状的情况下所进行的部分改变;convert指进行全部或局部改变以适应新的功能或用途,三项均不符合题意,故排除。
转载请注明原文地址:https://jikaoti.com/ti/OIX7FFFM
0
考研英语一
相关试题推荐
Rememberbooks?Theywerethosepiecesofpaperwithwordsprintedonthem【C1】______inbetweentwo,sometimes,【C2】______covers.
Judgingfromrecentsurveys,mostexpertsinsleepbehavioragreethatthereisvirtuallyanepidemicofsleepinessinthenatio
Judgingfromrecentsurveys,mostexpertsinsleepbehavioragreethatthereisvirtuallyanepidemicofsleepinessinthenatio
InApril,BritishresearchersatUniversityCollegeLondonfoundthat,ratherthantherecommendedfive,sevendailyportionsof
InApril,BritishresearchersatUniversityCollegeLondonfoundthat,ratherthantherecommendedfive,sevendailyportionsof
InApril,BritishresearchersatUniversityCollegeLondonfoundthat,ratherthantherecommendedfive,sevendailyportionsof
InApril,BritishresearchersatUniversityCollegeLondonfoundthat,ratherthantherecommendedfive,sevendailyportionsof
InApril,BritishresearchersatUniversityCollegeLondonfoundthat,ratherthantherecommendedfive,sevendailyportionsof
随机试题
试述专制型、放任型以及民主型师生关系的特点。
Theoryisbasedonpracticeand______servespractice.
患者男,32岁,鼻涕带血2个月余,检查见中鼻道脓液,中鼻甲息肉样变。为明确诊断,应行检查
阿仑膦酸钠为
引起根尖周炎的物理因素不包括
"主液"的腑是()
基金债券托管账户在交易当日进行核对,如无交易每()核对一次。
若假设检验HH0:新工艺不比旧工艺好,H1新工艺好于旧工艺,则下列属于犯第二类错误的是()。
受众(华东师大2005研;华中师大2005研)
食品安全问题是关系到千千万万人民群众切身利益的社会问题。可是在中国,重大食品安全事件频繁发生,食品安全问题日益严峻。某些没有诚信的商人为了追求利润最大化,不惜往人们每天食用的食品当中添加种类繁多的非法化学添加剂(additive),极大损害了人们的身体健康
最新回复
(
0
)